Pigmentation Disorders Treatment Market, By Disorder Type (Melasma, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation (PIH), and Others), By Drug Type (Corticosteroids, Calcineurin Inhibitors, Janus kinase inhibitor, Melanin Synthesis Inhibitor, and
Pigmentation Disorders Treatment Market, By Disorder Type (Melasma, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation (PIH), and Others), By Drug Type (Corticosteroids, Calcineurin Inhibitors, Janus kinase inhibitor, Melanin Synthesis Inhibitor, and Others), By Route of Administration (Oral, Topical, and Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Pigmentation disorders refer to conditions characterized by changes in skin color that are usually caused due to excess or uneven distribution of melanin. The global pigmentation disorders treatment market has been growing significantly over the recent past owing to the rising prevalence of conditions like melasma, vitiligo, and post-inflammatory hyperpigmentation. Various factors such as increasing awareness regarding pigmentation treatment options, growing aging population vulnerable to such disorders, and continual launch of advanced therapeutics are fueling the market expansion. However, high cost of sophisticated treatments, risks and side effects associated with certain medications remain major challenges for the market.
Market Dynamics:
The global pigmentation disorders treatment market is primarily driven by the increasing prevalence of pigmentation disorders worldwide due to genetic predisposition as well as changes in lifestyle habits. According to recent estimates, nearly 1-2% of global population suffers from vitiligo while prevalence of melasma ranges between 4-10%. Growing geriatric population also prone to such skin conditions acts as a high-impact driver. Moreover, continual development of newer topical and oral medications with fewer side effects along with entry of biosimilars is creating ample opportunities in this space. However, the market growth can be hampered by certain factors including stringent regulations for approval of melanogenesis inhibitors, reluctance towards cosmetic procedures due to social taboo, and high costs involved particularly in emerging nations.
Key Features of the Study:
This report provides in-depth analysis of the global pigmentation disorders treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pigmentation disorders treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study Abbvie Inc., Edesa Biotech, Inc., Amgen, Inc., Pfizer Inc., CLINUVEL PHARMACEUTICALS LTD, Uniza Group, Dr. Reddy’s Laboratories Ltd., Roivant Sciences Ltd., Incyte, Aclaris Therapeutics, Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Viatris Inc., GSK plc., Vyne Therapeutics Inc., Temprian Therapeutics Inc., Arrien Pharmaceuticals, LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global pigmentation disorders treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pigmentation disorders treatment market.
Detailed Segmentation-
By Disorder Type:
Melasma
Vitiligo
Albinism
Post-Inflammatory Hyperpigmentation (PIH)
Others
By Drug Type:
Corticosteroids
Calcineurin Inhibitors
Janus kinase (JAK) inhibitor
Melanin Synthesis Inhibitor
Others
By Route of Administration:
Oral
Topical
Other
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Abbvie Inc.
Edesa Biotech, Inc.
Amgen, Inc.
Pfizer Inc.
CLINUVEL PHARMACEUTICALS LTD
Uniza Group
Reddy’s Laboratories Ltd.
Roivant Sciences Ltd.
Incyte
Aclaris Therapeutics, Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Viatris Inc.
GSK plc.
Vyne Therapeutics Inc.
Temprian Therapeutics Inc.
Arrien Pharmaceuticals, LLC
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Therapy Type
Market Snapshot, By Indication
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Recent Developments
Regulatory Scenario
Technological Advancements
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Fundings and Investments
PEST Analysis
Porter’s Analysis
4. Global Cell Therapy Market- Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the market
5. Global Cell Therapy Market, By Therapy Type, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Stem Cells
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
T-cells
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Dendritic Cells
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
NK-cells
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
6. Global Cell Therapy Market, By Indication, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Oncology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Cardiology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Neurology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
7. Global Cell Therapy Market, By End User, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Hospitals
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Clinics
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Research Institutes
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
8. Global Cell Therapy Market, By Region, 2019 – 2031, (USD Mn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Mn)